A method for glycemic management of gestational diabetes based on a dietary inflammation index
By calculating the dietary inflammation index and using personalized dietary interventions, the problem that traditional dietary interventions cannot comprehensively improve blood glucose levels in pregnant women with gestational diabetes has been solved, achieving precise dietary management and blood glucose control.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CHONGQING MEDICAL UNIVERSITY
- Filing Date
- 2026-04-03
- Publication Date
- 2026-07-10
AI Technical Summary
Current technologies lack scientific dietary strategies to comprehensively improve blood sugar levels in pregnant women with gestational diabetes. Traditional dietary interventions mainly focus on carbohydrate intake and fail to effectively consider the impact of diet on inflammation.
By calculating the dietary inflammation index and combining carbohydrates and inflammation, a personalized dietary management model is established, including information input, dietary inflammation index calculation, blood glucose risk prediction, individualized dietary intervention, and blood glucose monitoring and adjustment, to generate a precise dietary plan.
It enables precise management of blood glucose in pregnant women with gestational diabetes, calculates blood glucose risk in advance, provides personalized dietary intervention, and automatically adjusts diet according to blood glucose changes, forming a closed-loop management system.
Smart Images

Figure CN122369816A_ABST